Stock ScreenerStock IdeasZen Ratings + Top Analysts
Stocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Nov 8, 2025
The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.

Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
PTC
PTC INC
NASDAQ
Software - Application
A$20.84B$173.931.25%$885.58M40.83x0.77
United States
43
TPR
TAPESTRY INC
NYSE
Luxury Goods
A$20.22B$98.814.93%$598.20M72.65x14.93
United States
36
JAZZ
JAZZ PHARMACEUTICALS PLC
NASDAQ
Biotechnology
A$8.15B$134.05-2.16%$182.64M-22.38x1.87
Ireland
16
MOG.A
MOOG INC
NYSE
Aerospace & Defense
A$6.33B$199.930.79%$436.71M30.02x1.26
United States
28
SGHC
SUPER GROUP (SGHC) LTD
NYSE
Gambling
A$5.94B$11.75-1.96%N/A23.59x0.60
Guernsey
35
GTES
GATES INDUSTRIAL CORP PLC
NYSE
Specialty Industrial Machinery
A$5.56B$21.532.74%$672.10M23.40x1.02
United States
37
CALX
CALIX INC
NYSE
Software - Application
A$4.27B$64.37-0.53%$10.21M-643.70x0.19
United States
31
DLO
DLOCAL LTD
NASDAQ
Software - Infrastructure
A$3.99B$13.60-0.07%$243.80M26.67x1.73
Uruguay
53
RSI
RUSH STREET INTERACTIVE INC
NYSE
Gambling
A$3.80B$16.554.17%-$33.04M50.15x2.40
United States
50
TPC
TUTOR PERINI CORP
NYSE
Engineering & Construction
A$3.55B$67.40-6.62%$108.27M-124.81x3.28
United States
28
MIRM
MIRUM PHARMACEUTICALS INC
NASDAQ
Biotechnology
A$3.40B$67.720.58%-$17.20M-55.97x1.85
United States
26
FOLD
AMICUS THERAPEUTICS INC
NASDAQ
Biotechnology
A$2.74B$8.90-0.34%$33.06M-74.17x2.99
United States
31
EXTR
EXTREME NETWORKS INC
NASDAQ
Communication Equipment
A$2.34B$17.51-0.51%$65.83M250.14x15.82
United States
34
SPNT
SIRIUSPOINT LTD
NYSE
Insurance - Reinsurance
A$2.26B$19.372.32%$339.10M11.67x4.64
Bermuda
34
IHS
IHS HOLDING LTD
NYSE
Telecom Services
A$2.15B$6.413.12%N/A18.85x-16.94
United Kingdom
28
ARDT
ARDENT HEALTH INC
NYSE
Medical Care Facilities
A$2.07B$14.46-0.41%$541.00M7.77x2.70
United States
42
FIVN
FIVE9 INC
NASDAQ
Software - Infrastructure
A$1.66B$21.54-7.89%$98.42M165.69x1.38
United States
54
BLBD
BLUE BIRD CORP
NASDAQ
Auto Manufacturers
A$1.60B$50.54-0.36%$175.74M13.92x1.59
United States
46
BCRX
BIOCRYST PHARMACEUTICALS INC
NASDAQ
Biotechnology
A$1.48B$7.030.85%$63.44M-39.06x-2.08
United States
17
CRTO
CRITEO SA
NASDAQ
Advertising Agencies
A$1.18B$22.50-4.80%$219.28M7.21x0.79
France
47
NRDS
NERDWALLET INC
NASDAQ
Internet Content & Information
A$892.66M$11.9813.86%$51.20M30.72x0.28
United States
48
UDMY
UDEMY INC
NASDAQ
Education & Training Services
A$759.70M$5.19-0.77%$28.86M-173.00x1.79
United States
23
TBPH
THERAVANCE BIOPHARMA INC
NASDAQ
Biotechnology
A$748.87M$14.87-0.81%$48.42M59.48x0.90
Cayman Islands
36
LYTS
LSI INDUSTRIES INC
NASDAQ
Electronic Components
A$630.08M$20.65-5.86%$48.74M25.18x0.72
United States
40
BWMN
BOWMAN CONSULTING GROUP LTD
NASDAQ
Engineering & Construction
A$593.85M$34.46-5.57%$24.06M215.38x1.17
United States
47
AKBA
AKEBIA THERAPEUTICS INC
NASDAQ
Biotechnology
A$527.90M$2.011.49%$10.87M-9.14x11.62
United States
25
KMDA
KAMADA LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
A$380.68M$6.620.60%$34.21M20.06x0.42
Israel
47
EGHT
8X8 INC
NASDAQ
Software - Application
A$268.65M$1.97-2.54%$41.70M-12.31x4.34
United States
16
NATR
NATURES SUNSHINE PRODUCTS INC
NASDAQ
Packaged Foods
A$242.14M$13.7330.52%$43.34M17.83x0.56
United States
47
INFU
INFUSYSTEM HOLDINGS INC
NYSEMKT
Medical Instruments & Supplies
A$209.26M$10.29-3.60%$24.16M39.58x0.78
United States
42
CXDO
CREXENDO INC
NASDAQ
Telecom Services
A$207.43M$6.75-1.33%$7.94M45.00x0.24
United States
44
ELMD
ELECTROMED INC
NYSEMKT
Medical Devices
A$203.22M$24.34-0.70%$11.32M27.35x0.25
United States
51

Upgrade to Premium to View More

Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More

Already have access to Premium? Sign In
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.